Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05804045
Title Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Abbisko Therapeutics Co, Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | ESP | CAN


No variant requirements are available.